TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
-16.3%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$244M
AUM Growth
+$244M
(-34%)
Cap. Flow
-$8.18M
Cap. Flow
% of AUM
-3.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$8.18M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.39B
| $99.5M | 40.69% |
5,104,130
-419,901
| -8% | -$8.18M |
|
2
Pliant Therapeutics
PLRX
$103M
| $46.8M | 19.13% |
5,839,160
| – | – |
|
3
Voyager Therapeutics
VYGR
$199M
| $37.8M | 15.45% |
6,391,176
| – | – |
|
4
Nurix Therapeutics
NRIX
$696M
| $24.4M | 9.96% |
1,922,549
| – | – |
|
5
Fulcrum Therapeutics
FULC
$347M
| $19.4M | 7.94% |
3,962,202
| – | – |
|
|
DBTX
6
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $13.2M | 5.41% |
3,139,685
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.48M | 1.42% |
1,148,780
| – | – |
|